For diagnosis and treatment of infectious diseases, Michigan Medicine provides complete outpatient consultation and continuing care for patients with a variety of conditions caused by bacteria, viruses, fungi, and parasites, ranging from common infections to complex infections.
We offer our patients treatment for infectious conditions including:
- Endocarditis
- Clostridium Difficile Colitis
- Cellulitis
- CMV disease
- Fever of Unknown Origin
- HIV-AIDS Treatment Program
- Soft tissue infections
- Animal and Human Bites
- Parasitic infestations and travel related infections
- Bone and Joint infections
- Post-operative infections
- Pneumonias
- Infections in immune compromised patients, including organ and bone marrow transplant patients
- Positive PPD skin test
- Infection with Tuberculosis
- Infected pressure ulcers/osteomyelitis
We have established several programs and clinics in response to emerging and growing needs over the years:
Fecal Microbiota Transplant Program
The Fecal Microbiota Transplant Program was established in 2013 and was implemented to address the rising number of patients being diagnosed with recurrent Clostridium difficile infection, also called CDI or C. diff., a serious bacterial infection that can cause inflammation of the colon, diarrhea, fever, and abdominal cramps, and can sometimes result in death. C. diff primarily occurs when the indigenous bacteria in a person’s gut is removed by an antibiotic being used to treat a separate condition, thereby hindering the body’s ability to fight off C. diff.
Fecal Microbiota Transplant (FMT) is a procedure where healthy fecal material is placed into a person infected with C. diff. The goal of the FMT procedure is to repopulate the colon with healthy bacteria in the infected person and cure them of C. diff.
FMT is not approved by the FDA, but is currently accepted as an effective treatment in patients who have had more than 2 episodes of C. diff infection and who are able to tolerate this therapy.
Transplant Infectious Disease Service
Many patients need to take medications to prevent rejection of their transplanted organ or to prevent “graft versus host disease”. This suppression of the immune system makes organ and stem cell transplant recipients susceptible to a variety of infections. In 2005, we established the Transplant Infectious Disease Service to provide expertise and establish protocols for the prevention and treatment of infection that can occur in transplant patients. We provide inpatient and outpatient consultation and care to the Michigan Medicine Transplant Center, which performs over 300 transplants annually, making it the largest and most experienced transplant center in Michigan, and to the Bone Marrow Transplant Program, where over 200 adult stem cell transplants are performed annually. Our team works closely with the transplant surgeons and the transplant support team to provide the best possible care to our patients